img

Global Intravenous (IV) Iron Drugs Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Intravenous (IV) Iron Drugs Market Insights, Forecast to 2034

Global Intravenous (IV) Iron Drugs market is expected to reach to US$ 109.8 million in 2024, with a positive growth of %, compared with US$ 100.8 million in 2022. Backed with the increasing demand from downstream industries, Intravenous (IV) Iron Drugs industry is evaluated to reach US$ 172.4 million in 2029. The CAGR will be 7.8% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Intravenous (IV) Iron Drugs market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Intravenous (IV) Iron Drugs market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi US
Allergan
AMAG Pharmaceuticals
Dalichi Sankyo
Luitpold Pharmaceuticals
Pharmacosmos
Takeda Pharmaceutical
Segment by Type
Ferric Carboxymaltose
Iron Sucrose
Iron Dextran
Others

Segment by Application


Nephrology
Gynecology & Obstetrics
Gastroenterology
Oncology
Cardiology
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Intravenous (IV) Iron Drugs plant distribution, commercial date of Intravenous (IV) Iron Drugs, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Intravenous (IV) Iron Drugs introduction, etc. Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Intravenous (IV) Iron Drugs
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Intravenous (IV) Iron Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Intravenous (IV) Iron Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Ferric Carboxymaltose
1.2.3 Iron Sucrose
1.2.4 Iron Dextran
1.2.5 Others
1.3 Market by Application
1.3.1 Global Intravenous (IV) Iron Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Nephrology
1.3.3 Gynecology & Obstetrics
1.3.4 Gastroenterology
1.3.5 Oncology
1.3.6 Cardiology
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Intravenous (IV) Iron Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Intravenous (IV) Iron Drugs Revenue by Region
2.2.1 Global Intravenous (IV) Iron Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Intravenous (IV) Iron Drugs Revenue by Region (2018-2024)
2.2.3 Global Intravenous (IV) Iron Drugs Revenue by Region (2024-2029)
2.2.4 Global Intravenous (IV) Iron Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Intravenous (IV) Iron Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Intravenous (IV) Iron Drugs Sales by Region
2.4.1 Global Intravenous (IV) Iron Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Intravenous (IV) Iron Drugs Sales by Region (2018-2024)
2.4.3 Global Intravenous (IV) Iron Drugs Sales by Region (2024-2029)
2.4.4 Global Intravenous (IV) Iron Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Intravenous (IV) Iron Drugs Sales by Manufacturers
3.1.1 Global Intravenous (IV) Iron Drugs Sales by Manufacturers (2018-2024)
3.1.2 Global Intravenous (IV) Iron Drugs Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intravenous (IV) Iron Drugs in 2022
3.2 Global Intravenous (IV) Iron Drugs Revenue by Manufacturers
3.2.1 Global Intravenous (IV) Iron Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Intravenous (IV) Iron Drugs Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Intravenous (IV) Iron Drugs Revenue in 2022
3.3 Global Key Players of Intravenous (IV) Iron Drugs, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Intravenous (IV) Iron Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Intravenous (IV) Iron Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Intravenous (IV) Iron Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Intravenous (IV) Iron Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Intravenous (IV) Iron Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Intravenous (IV) Iron Drugs Sales by Type
4.1.1 Global Intravenous (IV) Iron Drugs Historical Sales by Type (2018-2024)
4.1.2 Global Intravenous (IV) Iron Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Intravenous (IV) Iron Drugs Sales Market Share by Type (2018-2029)
4.2 Global Intravenous (IV) Iron Drugs Revenue by Type
4.2.1 Global Intravenous (IV) Iron Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Intravenous (IV) Iron Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Intravenous (IV) Iron Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Intravenous (IV) Iron Drugs Price by Type
4.3.1 Global Intravenous (IV) Iron Drugs Price by Type (2018-2024)
4.3.2 Global Intravenous (IV) Iron Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Intravenous (IV) Iron Drugs Sales by Application
5.1.1 Global Intravenous (IV) Iron Drugs Historical Sales by Application (2018-2024)
5.1.2 Global Intravenous (IV) Iron Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Intravenous (IV) Iron Drugs Sales Market Share by Application (2018-2029)
5.2 Global Intravenous (IV) Iron Drugs Revenue by Application
5.2.1 Global Intravenous (IV) Iron Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Intravenous (IV) Iron Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Intravenous (IV) Iron Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Intravenous (IV) Iron Drugs Price by Application
5.3.1 Global Intravenous (IV) Iron Drugs Price by Application (2018-2024)
5.3.2 Global Intravenous (IV) Iron Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Intravenous (IV) Iron Drugs Market Size by Type
6.1.1 US & Canada Intravenous (IV) Iron Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Intravenous (IV) Iron Drugs Revenue by Type (2018-2029)
6.2 US & Canada Intravenous (IV) Iron Drugs Market Size by Application
6.2.1 US & Canada Intravenous (IV) Iron Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Intravenous (IV) Iron Drugs Revenue by Application (2018-2029)
6.3 US & Canada Intravenous (IV) Iron Drugs Market Size by Country
6.3.1 US & Canada Intravenous (IV) Iron Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Intravenous (IV) Iron Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Intravenous (IV) Iron Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Intravenous (IV) Iron Drugs Market Size by Type
7.1.1 Europe Intravenous (IV) Iron Drugs Sales by Type (2018-2029)
7.1.2 Europe Intravenous (IV) Iron Drugs Revenue by Type (2018-2029)
7.2 Europe Intravenous (IV) Iron Drugs Market Size by Application
7.2.1 Europe Intravenous (IV) Iron Drugs Sales by Application (2018-2029)
7.2.2 Europe Intravenous (IV) Iron Drugs Revenue by Application (2018-2029)
7.3 Europe Intravenous (IV) Iron Drugs Market Size by Country
7.3.1 Europe Intravenous (IV) Iron Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Intravenous (IV) Iron Drugs Sales by Country (2018-2029)
7.3.3 Europe Intravenous (IV) Iron Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Intravenous (IV) Iron Drugs Market Size
8.1.1 China Intravenous (IV) Iron Drugs Sales (2018-2029)
8.1.2 China Intravenous (IV) Iron Drugs Revenue (2018-2029)
8.2 China Intravenous (IV) Iron Drugs Market Size by Application
8.2.1 China Intravenous (IV) Iron Drugs Sales by Application (2018-2029)
8.2.2 China Intravenous (IV) Iron Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Intravenous (IV) Iron Drugs Market Size by Type
9.1.1 Asia Intravenous (IV) Iron Drugs Sales by Type (2018-2029)
9.1.2 Asia Intravenous (IV) Iron Drugs Revenue by Type (2018-2029)
9.2 Asia Intravenous (IV) Iron Drugs Market Size by Application
9.2.1 Asia Intravenous (IV) Iron Drugs Sales by Application (2018-2029)
9.2.2 Asia Intravenous (IV) Iron Drugs Revenue by Application (2018-2029)
9.3 Asia Intravenous (IV) Iron Drugs Sales by Region
9.3.1 Asia Intravenous (IV) Iron Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Intravenous (IV) Iron Drugs Revenue by Region (2018-2029)
9.3.3 Asia Intravenous (IV) Iron Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sanofi US
11.1.1 Sanofi US Company Information
11.1.2 Sanofi US Overview
11.1.3 Sanofi US Intravenous (IV) Iron Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Sanofi US Intravenous (IV) Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi US Recent Developments
11.2 Allergan
11.2.1 Allergan Company Information
11.2.2 Allergan Overview
11.2.3 Allergan Intravenous (IV) Iron Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Allergan Intravenous (IV) Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Allergan Recent Developments
11.3 AMAG Pharmaceuticals
11.3.1 AMAG Pharmaceuticals Company Information
11.3.2 AMAG Pharmaceuticals Overview
11.3.3 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AMAG Pharmaceuticals Recent Developments
11.4 Dalichi Sankyo
11.4.1 Dalichi Sankyo Company Information
11.4.2 Dalichi Sankyo Overview
11.4.3 Dalichi Sankyo Intravenous (IV) Iron Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Dalichi Sankyo Intravenous (IV) Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Dalichi Sankyo Recent Developments
11.5 Luitpold Pharmaceuticals
11.5.1 Luitpold Pharmaceuticals Company Information
11.5.2 Luitpold Pharmaceuticals Overview
11.5.3 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Luitpold Pharmaceuticals Recent Developments
11.6 Pharmacosmos
11.6.1 Pharmacosmos Company Information
11.6.2 Pharmacosmos Overview
11.6.3 Pharmacosmos Intravenous (IV) Iron Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Pharmacosmos Intravenous (IV) Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pharmacosmos Recent Developments
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Information
11.7.2 Takeda Pharmaceutical Overview
11.7.3 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Takeda Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Intravenous (IV) Iron Drugs Industry Chain Analysis
12.2 Intravenous (IV) Iron Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Intravenous (IV) Iron Drugs Production Mode & Process
12.4 Intravenous (IV) Iron Drugs Sales and Marketing
12.4.1 Intravenous (IV) Iron Drugs Sales Channels
12.4.2 Intravenous (IV) Iron Drugs Distributors
12.5 Intravenous (IV) Iron Drugs Customers
13 Market Dynamics
13.1 Intravenous (IV) Iron Drugs Industry Trends
13.2 Intravenous (IV) Iron Drugs Market Drivers
13.3 Intravenous (IV) Iron Drugs Market Challenges
13.4 Intravenous (IV) Iron Drugs Market Restraints
14 Key Findings in The Global Intravenous (IV) Iron Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Intravenous (IV) Iron Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Ferric Carboxymaltose
Table 3. Major Manufacturers of Iron Sucrose
Table 4. Major Manufacturers of Iron Dextran
Table 5. Major Manufacturers of Others
Table 6. Global Intravenous (IV) Iron Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Intravenous (IV) Iron Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Intravenous (IV) Iron Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Intravenous (IV) Iron Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Intravenous (IV) Iron Drugs Revenue Market Share by Region (2018-2024)
Table 11. Global Intravenous (IV) Iron Drugs Revenue Market Share by Region (2024-2029)
Table 12. Global Intravenous (IV) Iron Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Intravenous (IV) Iron Drugs Sales by Region (2018-2024) & (K Units)
Table 14. Global Intravenous (IV) Iron Drugs Sales by Region (2024-2029) & (K Units)
Table 15. Global Intravenous (IV) Iron Drugs Sales Market Share by Region (2018-2024)
Table 16. Global Intravenous (IV) Iron Drugs Sales Market Share by Region (2024-2029)
Table 17. Global Intravenous (IV) Iron Drugs Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Intravenous (IV) Iron Drugs Sales Share by Manufacturers (2018-2024)
Table 19. Global Intravenous (IV) Iron Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Intravenous (IV) Iron Drugs Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Intravenous (IV) Iron Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Intravenous (IV) Iron Drugs Price by Manufacturers 2018-2024 (USD/Unit)
Table 23. Global Intravenous (IV) Iron Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Intravenous (IV) Iron Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Iron Drugs as of 2022)
Table 25. Global Key Manufacturers of Intravenous (IV) Iron Drugs, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Intravenous (IV) Iron Drugs, Product Offered and Application
Table 27. Global Key Manufacturers of Intravenous (IV) Iron Drugs, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Intravenous (IV) Iron Drugs Sales by Type (2018-2024) & (K Units)
Table 30. Global Intravenous (IV) Iron Drugs Sales by Type (2024-2029) & (K Units)
Table 31. Global Intravenous (IV) Iron Drugs Sales Share by Type (2018-2024)
Table 32. Global Intravenous (IV) Iron Drugs Sales Share by Type (2024-2029)
Table 33. Global Intravenous (IV) Iron Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Intravenous (IV) Iron Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Intravenous (IV) Iron Drugs Revenue Share by Type (2018-2024)
Table 36. Global Intravenous (IV) Iron Drugs Revenue Share by Type (2024-2029)
Table 37. Intravenous (IV) Iron Drugs Price by Type (2018-2024) & (USD/Unit)
Table 38. Global Intravenous (IV) Iron Drugs Price Forecast by Type (2024-2029) & (USD/Unit)
Table 39. Global Intravenous (IV) Iron Drugs Sales by Application (2018-2024) & (K Units)
Table 40. Global Intravenous (IV) Iron Drugs Sales by Application (2024-2029) & (K Units)
Table 41. Global Intravenous (IV) Iron Drugs Sales Share by Application (2018-2024)
Table 42. Global Intravenous (IV) Iron Drugs Sales Share by Application (2024-2029)
Table 43. Global Intravenous (IV) Iron Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Intravenous (IV) Iron Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Intravenous (IV) Iron Drugs Revenue Share by Application (2018-2024)
Table 46. Global Intravenous (IV) Iron Drugs Revenue Share by Application (2024-2029)
Table 47. Intravenous (IV) Iron Drugs Price by Application (2018-2024) & (USD/Unit)
Table 48. Global Intravenous (IV) Iron Drugs Price Forecast by Application (2024-2029) & (USD/Unit)
Table 49. US & Canada Intravenous (IV) Iron Drugs Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Intravenous (IV) Iron Drugs Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Intravenous (IV) Iron Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Intravenous (IV) Iron Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Intravenous (IV) Iron Drugs Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Intravenous (IV) Iron Drugs Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Intravenous (IV) Iron Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Intravenous (IV) Iron Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Intravenous (IV) Iron Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Intravenous (IV) Iron Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Intravenous (IV) Iron Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Intravenous (IV) Iron Drugs Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Intravenous (IV) Iron Drugs Sales by Country (2024-2029) & (K Units)
Table 62. Europe Intravenous (IV) Iron Drugs Sales by Type (2018-2024) & (K Units)
Table 63. Europe Intravenous (IV) Iron Drugs Sales by Type (2024-2029) & (K Units)
Table 64. Europe Intravenous (IV) Iron Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Intravenous (IV) Iron Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Intravenous (IV) Iron Drugs Sales by Application (2018-2024) & (K Units)
Table 67. Europe Intravenous (IV) Iron Drugs Sales by Application (2024-2029) & (K Units)
Table 68. Europe Intravenous (IV) Iron Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Intravenous (IV) Iron Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Intravenous (IV) Iron Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Intravenous (IV) Iron Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Intravenous (IV) Iron Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Intravenous (IV) Iron Drugs Sales by Country (2018-2024) & (K Units)
Table 74. Europe Intravenous (IV) Iron Drugs Sales by Country (2024-2029) & (K Units)
Table 75. China Intravenous (IV) Iron Drugs Sales by Type (2018-2024) & (K Units)
Table 76. China Intravenous (IV) Iron Drugs Sales by Type (2024-2029) & (K Units)
Table 77. China Intravenous (IV) Iron Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Intravenous (IV) Iron Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Intravenous (IV) Iron Drugs Sales by Application (2018-2024) & (K Units)
Table 80. China Intravenous (IV) Iron Drugs Sales by Application (2024-2029) & (K Units)
Table 81. China Intravenous (IV) Iron Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Intravenous (IV) Iron Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Intravenous (IV) Iron Drugs Sales by Type (2018-2024) & (K Units)
Table 84. Asia Intravenous (IV) Iron Drugs Sales by Type (2024-2029) & (K Units)
Table 85. Asia Intravenous (IV) Iron Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Intravenous (IV) Iron Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Intravenous (IV) Iron Drugs Sales by Application (2018-2024) & (K Units)
Table 88. Asia Intravenous (IV) Iron Drugs Sales by Application (2024-2029) & (K Units)
Table 89. Asia Intravenous (IV) Iron Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Intravenous (IV) Iron Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Intravenous (IV) Iron Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Intravenous (IV) Iron Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Intravenous (IV) Iron Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Intravenous (IV) Iron Drugs Sales by Region (2018-2024) & (K Units)
Table 95. Asia Intravenous (IV) Iron Drugs Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Sales by Country (2024-2029) & (K Units)
Table 109. Sanofi US Company Information
Table 110. Sanofi US Description and Major Businesses
Table 111. Sanofi US Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. Sanofi US Intravenous (IV) Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Sanofi US Recent Developments
Table 114. Allergan Company Information
Table 115. Allergan Description and Major Businesses
Table 116. Allergan Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. Allergan Intravenous (IV) Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Allergan Recent Developments
Table 119. AMAG Pharmaceuticals Company Information
Table 120. AMAG Pharmaceuticals Description and Major Businesses
Table 121. AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. AMAG Pharmaceuticals Recent Developments
Table 124. Dalichi Sankyo Company Information
Table 125. Dalichi Sankyo Description and Major Businesses
Table 126. Dalichi Sankyo Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Dalichi Sankyo Intravenous (IV) Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Dalichi Sankyo Recent Developments
Table 129. Luitpold Pharmaceuticals Company Information
Table 130. Luitpold Pharmaceuticals Description and Major Businesses
Table 131. Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Luitpold Pharmaceuticals Recent Developments
Table 134. Pharmacosmos Company Information
Table 135. Pharmacosmos Description and Major Businesses
Table 136. Pharmacosmos Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. Pharmacosmos Intravenous (IV) Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Pharmacosmos Recent Developments
Table 139. Takeda Pharmaceutical Company Information
Table 140. Takeda Pharmaceutical Description and Major Businesses
Table 141. Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 142. Takeda Pharmaceutical Intravenous (IV) Iron Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Takeda Pharmaceutical Recent Developments
Table 144. Key Raw Materials Lists
Table 145. Raw Materials Key Suppliers Lists
Table 146. Intravenous (IV) Iron Drugs Distributors List
Table 147. Intravenous (IV) Iron Drugs Customers List
Table 148. Intravenous (IV) Iron Drugs Market Trends
Table 149. Intravenous (IV) Iron Drugs Market Drivers
Table 150. Intravenous (IV) Iron Drugs Market Challenges
Table 151. Intravenous (IV) Iron Drugs Market Restraints
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous (IV) Iron Drugs Product Picture
Figure 2. Global Intravenous (IV) Iron Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Intravenous (IV) Iron Drugs Market Share by Type in 2022 & 2029
Figure 4. Ferric Carboxymaltose Product Picture
Figure 5. Iron Sucrose Product Picture
Figure 6. Iron Dextran Product Picture
Figure 7. Others Product Picture
Figure 8. Global Intravenous (IV) Iron Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Intravenous (IV) Iron Drugs Market Share by Application in 2022 & 2029
Figure 10. Nephrology
Figure 11. Gynecology & Obstetrics
Figure 12. Gastroenterology
Figure 13. Oncology
Figure 14. Cardiology
Figure 15. Others
Figure 16. Intravenous (IV) Iron Drugs Report Years Considered
Figure 17. Global Intravenous (IV) Iron Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Intravenous (IV) Iron Drugs Revenue 2018-2029 (US$ Million)
Figure 19. Global Intravenous (IV) Iron Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 20. Global Intravenous (IV) Iron Drugs Revenue Market Share by Region (2018-2029)
Figure 21. Global Intravenous (IV) Iron Drugs Sales 2018-2029 ((K Units)
Figure 22. Global Intravenous (IV) Iron Drugs Sales Market Share by Region (2018-2029)
Figure 23. US & Canada Intravenous (IV) Iron Drugs Sales YoY (2018-2029) & (K Units)
Figure 24. US & Canada Intravenous (IV) Iron Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Europe Intravenous (IV) Iron Drugs Sales YoY (2018-2029) & (K Units)
Figure 26. Europe Intravenous (IV) Iron Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 27. China Intravenous (IV) Iron Drugs Sales YoY (2018-2029) & (K Units)
Figure 28. China Intravenous (IV) Iron Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Asia (excluding China) Intravenous (IV) Iron Drugs Sales YoY (2018-2029) & (K Units)
Figure 30. Asia (excluding China) Intravenous (IV) Iron Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 31. Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Sales YoY (2018-2029) & (K Units)
Figure 32. Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 33. The Intravenous (IV) Iron Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 34. The Top 5 and 10 Largest Manufacturers of Intravenous (IV) Iron Drugs in the World: Market Share by Intravenous (IV) Iron Drugs Revenue in 2022
Figure 35. Global Intravenous (IV) Iron Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 36. Global Intravenous (IV) Iron Drugs Sales Market Share by Type (2018-2029)
Figure 37. Global Intravenous (IV) Iron Drugs Revenue Market Share by Type (2018-2029)
Figure 38. Global Intravenous (IV) Iron Drugs Sales Market Share by Application (2018-2029)
Figure 39. Global Intravenous (IV) Iron Drugs Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Intravenous (IV) Iron Drugs Sales Market Share by Type (2018-2029)
Figure 41. US & Canada Intravenous (IV) Iron Drugs Revenue Market Share by Type (2018-2029)
Figure 42. US & Canada Intravenous (IV) Iron Drugs Sales Market Share by Application (2018-2029)
Figure 43. US & Canada Intravenous (IV) Iron Drugs Revenue Market Share by Application (2018-2029)
Figure 44. US & Canada Intravenous (IV) Iron Drugs Revenue Share by Country (2018-2029)
Figure 45. US & Canada Intravenous (IV) Iron Drugs Sales Share by Country (2018-2029)
Figure 46. U.S. Intravenous (IV) Iron Drugs Revenue (2018-2029) & (US$ Million)
Figure 47. Canada Intravenous (IV) Iron Drugs Revenue (2018-2029) & (US$ Million)
Figure 48. Europe Intravenous (IV) Iron Drugs Sales Market Share by Type (2018-2029)
Figure 49. Europe Intravenous (IV) Iron Drugs Revenue Market Share by Type (2018-2029)
Figure 50. Europe Intravenous (IV) Iron Drugs Sales Market Share by Application (2018-2029)
Figure 51. Europe Intravenous (IV) Iron Drugs Revenue Market Share by Application (2018-2029)
Figure 52. Europe Intravenous (IV) Iron Drugs Revenue Share by Country (2018-2029)
Figure 53. Europe Intravenous (IV) Iron Drugs Sales Share by Country (2018-2029)
Figure 54. Germany Intravenous (IV) Iron Drugs Revenue (2018-2029) & (US$ Million)
Figure 55. France Intravenous (IV) Iron Drugs Revenue (2018-2029) & (US$ Million)
Figure 56. U.K. Intravenous (IV) Iron Drugs Revenue (2018-2029) & (US$ Million)
Figure 57. Italy Intravenous (IV) Iron Drugs Revenue (2018-2029) & (US$ Million)
Figure 58. Russia Intravenous (IV) Iron Drugs Revenue (2018-2029) & (US$ Million)
Figure 59. China Intravenous (IV) Iron Drugs Sales Market Share by Type (2018-2029)
Figure 60. China Intravenous (IV) Iron Drugs Revenue Market Share by Type (2018-2029)
Figure 61. China Intravenous (IV) Iron Drugs Sales Market Share by Application (2018-2029)
Figure 62. China Intravenous (IV) Iron Drugs Revenue Market Share by Application (2018-2029)
Figure 63. Asia Intravenous (IV) Iron Drugs Sales Market Share by Type (2018-2029)
Figure 64. Asia Intravenous (IV) Iron Drugs Revenue Market Share by Type (2018-2029)
Figure 65. Asia Intravenous (IV) Iron Drugs Sales Market Share by Application (2018-2029)
Figure 66. Asia Intravenous (IV) Iron Drugs Revenue Market Share by Application (2018-2029)
Figure 67. Asia Intravenous (IV) Iron Drugs Revenue Share by Region (2018-2029)
Figure 68. Asia Intravenous (IV) Iron Drugs Sales Share by Region (2018-2029)
Figure 69. Japan Intravenous (IV) Iron Drugs Revenue (2018-2029) & (US$ Million)
Figure 70. South Korea Intravenous (IV) Iron Drugs Revenue (2018-2029) & (US$ Million)
Figure 71. China Taiwan Intravenous (IV) Iron Drugs Revenue (2018-2029) & (US$ Million)
Figure 72. Southeast Asia Intravenous (IV) Iron Drugs Revenue (2018-2029) & (US$ Million)
Figure 73. India Intravenous (IV) Iron Drugs Revenue (2018-2029) & (US$ Million)
Figure 74. Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Sales Market Share by Type (2018-2029)
Figure 75. Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Revenue Market Share by Type (2018-2029)
Figure 76. Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Sales Market Share by Application (2018-2029)
Figure 77. Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Revenue Market Share by Application (2018-2029)
Figure 78. Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Revenue Share by Country (2018-2029)
Figure 79. Middle East, Africa and Latin America Intravenous (IV) Iron Drugs Sales Share by Country (2018-2029)
Figure 80. Brazil Intravenous (IV) Iron Drugs Revenue (2018-2029) & (US$ Million)
Figure 81. Mexico Intravenous (IV) Iron Drugs Revenue (2018-2029) & (US$ Million)
Figure 82. Turkey Intravenous (IV) Iron Drugs Revenue (2018-2029) & (US$ Million)
Figure 83. Israel Intravenous (IV) Iron Drugs Revenue (2018-2029) & (US$ Million)
Figure 84. GCC Countries Intravenous (IV) Iron Drugs Revenue (2018-2029) & (US$ Million)
Figure 85. Intravenous (IV) Iron Drugs Value Chain
Figure 86. Intravenous (IV) Iron Drugs Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries